Real-time enrollment status for this hereditary cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:09 PM UTC
| NCT Number | NCT06073626 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 428 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | October 28, 2025 (Oct 28, 2025) |
As of July 13, 2026: Clinical trial NCT06073626 is currently recruiting participants. This clinical trial study for hereditary cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06073626 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06073626 was last updated Oct 28, 2025 (October 28, 2025). HelloStudys verifies this status automatically.